Location History:
- Berlin, DE (1994 - 2020)
- Weinheim, DE (2020)
- Singapore, SG (2014 - 2021)
Company Filing History:
10 out of 68 
1 out of 510 
1 out of 6,662 
Years Active: 1994-2021
Title: The Innovative Contributions of Matthias Schuster
Introduction
Matthias Schuster, an esteemed inventor based in Berlin, Germany, has made significant contributions to the field of biotechnology through his innovative inventions. With a remarkable portfolio of 11 patents, Schuster's work primarily revolves around methods and nucleic acids for analyzing cellular proliferative disorders. His inventions have paved the way for advancements in the diagnosis and treatment of various medical conditions.
Latest Patents
Among his latest patents, Schuster has developed groundbreaking methods that enhance the detection and differentiation of liver and colorectal cell proliferative disorders. His invention provides essential tools, including nucleic acids and kits, aimed at improving the diagnosis and treatment options for patients suffering from these disorders.
Additionally, Schuster has patented methods for determining the presence or absence of methylation in DNA samples. These patents detail techniques for isolating DNA from remote samples, enabling researchers to analyze methylation patterns effectively. His innovations also include methods for whole genome amplification of bisulfite-treated DNA and techniques for assessing methylation in human DNA from various biological samples, such as blood and urine.
Career Highlights
Matthias Schuster has had a notable career, collaborating with reputable companies in the biotechnology and pharmaceuticals sector. He has worked with Epigenomics AG and Hoechst Aktiengesellschaft, where he applied his expertise to drive advancements in genetic research and diagnostics.
Collaborations
Throughout his professional journey, Schuster has joined forces with talented individuals in the field, including his coworkers Andrew Z. Sledziewski and Reimo Tetzner. These collaborations have likely contributed to the successful execution and development of his innovative projects.
Conclusion
Matthias Schuster's contributions to biotechnology are invaluable, with his patents demonstrating a commitment to improving healthcare through innovative solutions. His work not only enhances our understanding of cellular disorders but also provides critical tools for medical professionals, ultimately benefiting patients in need of advanced diagnostic options.